Big Pharma Split Corp.
PRM.TO
TSX
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.48% | 1,701.74% | 1.37% | 86.22% | -0.67% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.46% | -64.23% | -1.40% | -87.80% | 0.68% |
| Change in Net Operating Assets | -1.59% | 75.00% | 0.00% | -- | -- |
| Cash from Operations | -1.46% | 36.06% | -1.39% | -87.79% | 0.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | 96.97% | 0.00% | 82.14% | 0.00% |
| Issuance of Preferred Stock | 0.00% | 135.20% | 0.00% | 138.30% | 0.00% |
| Repurchase of Preferred Stock | -- | -- | -- | 100.00% | 0.00% |
| Total Dividends Paid | 1.47% | -8.25% | 1.41% | 11.43% | -0.70% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.47% | 76.29% | 1.41% | 86.49% | -0.68% |
| Foreign Exchange rate Adjustments | 0.00% | -200.00% | 0.00% | 123.08% | -8.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.48% | 825.35% | 1.53% | 54.08% | -0.71% |
